115 related articles for article (PubMed ID: 8216733)
21. Separation of the SOS-dependent and SOS-independent components of alkylating-agent mutagenesis.
Couto LB; Chaudhuri I; Donahue BA; Demple B; Essigmann JM
J Bacteriol; 1989 Aug; 171(8):4170-7. PubMed ID: 2666388
[TBL] [Abstract][Full Text] [Related]
22. The major, N2-dG adduct of (+)-anti-B[a]PDE shows a dramatically different mutagenic specificity (predominantly, G --> A) in a 5'-CGT-3' sequence context.
Shukla R; Liu T; Geacintov NE; Loechler EL
Biochemistry; 1997 Aug; 36(33):10256-61. PubMed ID: 9254624
[TBL] [Abstract][Full Text] [Related]
23. Mutagenic specificity of a derivative of 3-nitrobenzanthrone in the supF shuttle vector plasmids.
Kawanishi M; Enya T; Suzuki H; Takebe H; Matsui S; Yagi T
Chem Res Toxicol; 1998 Dec; 11(12):1468-73. PubMed ID: 9860489
[TBL] [Abstract][Full Text] [Related]
24. 7-Methoxy-2-nitronaphtho[2,1-b]furan (R7000)-induced mutation spectrum in the lacI gene of Escherichia coli: influence of SOS mutagenesis.
Touati E; Krin E; Quillardet P; Hofnung M
Carcinogenesis; 1996 Dec; 17(12):2543-50. PubMed ID: 9006087
[TBL] [Abstract][Full Text] [Related]
25. Analysis of point mutations in murine c-Ha-ras of skin tumors initiated with dibenz[a,j]anthracene and derivatives.
Gill RD; Beltrán L; Nettikumara AN; Harvey RG; Kootstra A; DiGiovanni J
Mol Carcinog; 1992; 6(1):53-9. PubMed ID: 1503644
[TBL] [Abstract][Full Text] [Related]
26. Site-specific frame-shift mutagenesis by the 1-nitropyrene-DNA adduct N-(deoxyguanosin-8-y1)-1-aminopyrene located in the (CG)3 sequence: effects of SOS, proofreading, and mismatch repair.
Malia SA; Vyas RR; Basu AK
Biochemistry; 1996 Apr; 35(14):4568-77. PubMed ID: 8605207
[TBL] [Abstract][Full Text] [Related]
27. Effects of the umuDC, mucAB, and samAB operons on the mutational specificity of chemical mutagenesis in Escherichia coli: I. Frameshift mutagenesis.
Watanabe M; Nohmi T; Ohta T
Mutat Res; 1994 Jan; 314(1):27-37. PubMed ID: 7504189
[TBL] [Abstract][Full Text] [Related]
28. Cobaltous chloride-induced mutagenesis in the supF tRNA gene of Escherichia coli.
Ogawa HI; Ohyama Y; Ohsumi Y; Kakimoto K; Kato Y; Shirai Y; Nunoshiba T; Yamamoto K
Mutagenesis; 1999 Mar; 14(2):249-53. PubMed ID: 10229930
[TBL] [Abstract][Full Text] [Related]
29. Mutagenic specificity of reductively activated 1-nitropyrene in Escherichia coli.
Malia SA; Basu AK
Biochemistry; 1995 Jan; 34(1):96-104. PubMed ID: 7819229
[TBL] [Abstract][Full Text] [Related]
30. Comparing the frequency and spectra of mutations induced when an SV-40 based shuttle vector containing covalently bound residues of structurally-related carcinogens replicates in human cells.
Maher VM; Yang JL; Mah MC; McCormick JJ
Mutat Res; 1989; 220(2-3):83-92. PubMed ID: 2538743
[TBL] [Abstract][Full Text] [Related]
31. Mutagenic specificity of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the supF shuttle vector system.
Endo H; Schut HA; Snyderwine EG
Cancer Res; 1994 Jul; 54(14):3745-51. PubMed ID: 8033094
[TBL] [Abstract][Full Text] [Related]
32. Escherichia coli mutator (Delta)polA is defective in base mismatch correction: the nature of in vivo DNA replication errors.
Tago Y; Imai M; Ihara M; Atofuji H; Nagata Y; Yamamoto K
J Mol Biol; 2005 Aug; 351(2):299-308. PubMed ID: 16005896
[TBL] [Abstract][Full Text] [Related]
33. Genetic analysis of the anti-mutagenic effect of genistein in Escherichia coli.
Yang Y; Fix D
Mutat Res; 2006 Aug; 600(1-2):193-206. PubMed ID: 16872640
[TBL] [Abstract][Full Text] [Related]
34. Mutagenic events induced by 4-hydroxyequilin in supF shuttle vector plasmid propagated in human cells.
Yasui M; Matsui S; Laxmi YR; Suzuki N; Kim SY; Shibutani S; Matsuda T
Carcinogenesis; 2003 May; 24(5):911-7. PubMed ID: 12771036
[TBL] [Abstract][Full Text] [Related]
35. Catabolite repression of SOS-dependent and SOS-independent spontaneous mutagenesis in stationary-phase Escherichia coli.
MacPhee DG; Ambrose M
Mutat Res; 2010 Apr; 686(1-2):84-9. PubMed ID: 20138895
[TBL] [Abstract][Full Text] [Related]
36. Ability of adducts formed in a shuttle vector by reactive metabolites of 1-nitropyrene and benzo(a)pyrene to induce mutations when the plasmid replicates in human cells.
Maher VM; Yang JL; McCormick JJ
Acta Biol Hung; 1990; 41(1-3):173-86. PubMed ID: 2128787
[TBL] [Abstract][Full Text] [Related]
37. Sequence specific mutagenesis of the major (+)-anti-benzo[a]pyrene diol epoxide-DNA adduct at a mutational hot spot in vitro and in Escherichia coli cells.
Hanrahan CJ; Bacolod MD; Vyas RR; Liu T; Geacintov NE; Loechler EL; Basu AK
Chem Res Toxicol; 1997 Apr; 10(4):369-77. PubMed ID: 9114972
[TBL] [Abstract][Full Text] [Related]
38. Reduction of ENU-induced transversion mutations by the isoflavone genistein in Escherichia coli.
Yang Y; Fix D
Mutat Res; 2001 Aug; 479(1-2):63-70. PubMed ID: 11470481
[TBL] [Abstract][Full Text] [Related]
39. Suppressible base substitution mutations induced by angelicin (isopsoralen) in the Escherichia coli lacI gene: implications for the mechanism of SOS mutagenesis.
Miller SS; Eisenstadt E
J Bacteriol; 1987 Jun; 169(6):2724-9. PubMed ID: 3294805
[TBL] [Abstract][Full Text] [Related]
40. [Bioluminescent analysis of the SOS-response of Escherichia coli cells].
Ptistsyn LR
Genetika; 1996 Mar; 32(3):354-8. PubMed ID: 8723628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
